Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $16.8500 (1.44%) ($15.9700 - $17.6700) on Thu. Mar. 24, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.11% (three month average) | RSI | 56 | Latest Price | $16.8500(1.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) IBB(52%) ARKG(50%) IWO(48%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -3.555% in a week (0% probabilities). VIXM(-18%) TLT(-13%) UUP(-9%) UNG(-3%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.555% (StdDev 7.11%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
Resistance Level | $16.97 | 5 Day Moving Average | $17.25(-2.32%) | 10 Day Moving Average | $16.7(0.9%) | 20 Day Moving Average | $16.97(-0.71%) | To recent high | -36.2% | To recent low | 20.3% | Market Cap | $1.252b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |